Characterization of the human monocyte high affinity Fc receptor (hu FcRI).

PubWeight™: 0.85‹?›

🔗 View Article (PMID 2967428)

Published in Mol Immunol on March 01, 1988

Authors

G Peltz1, K Frederick, C L Anderson, B M Peterlin

Author Affiliations

1: Howard Hughes Medical Institute, University of California, San Francisco 94143.

Articles by these authors

(truncated to the top 100)

Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (1988) 10.15

Amazonia through time: Andean uplift, climate change, landscape evolution, and biodiversity. Science (2010) 7.03

Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57

Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem (1994) 4.70

Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev (1989) 4.63

NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell (2001) 4.55

Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. Proc Natl Acad Sci U S A (1978) 4.02

Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc Natl Acad Sci U S A (1987) 3.47

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A (1996) 3.37

Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell (1990) 3.27

Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes. J Exp Med (1974) 3.21

Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem (2000) 3.13

Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J Exp Med (1977) 2.98

Structure--function relationships in HIV-1 Nef. EMBO Rep (2001) 2.87

Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79

HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity (1994) 2.63

Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immunol (1986) 2.53

The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J Virol (1998) 2.51

Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc Natl Acad Sci U S A (1994) 2.48

Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity (2000) 2.47

The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev (1997) 2.38

Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol (1989) 2.21

Biology of human immunoglobulin G Fc receptors. J Leukoc Biol (1991) 2.21

Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A (1994) 2.14

Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol Cell (1999) 2.09

Endocytic entry of HIV-1. Curr Biol (2000) 2.08

An investigation of the adequacy of MEDLINE searches for randomized controlled trials (RCTs) of the effects of mental health care. Psychol Med (1994) 2.08

Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity (1998) 2.08

Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J Immunol (1980) 2.03

Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line. J Biol Chem (1986) 2.01

Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol (1996) 1.88

Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc Natl Acad Sci U S A (1999) 1.87

Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils. J Exp Med (1986) 1.82

Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest (1985) 1.82

Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr Biol (1996) 1.81

Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology (1999) 1.70

The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol Cell Biol (1997) 1.70

B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc Natl Acad Sci U S A (1988) 1.70

Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J Virol (1992) 1.69

Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc Natl Acad Sci U S A (1996) 1.68

Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J Virol (1992) 1.68

Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol (2006) 1.68

The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J Virol (1993) 1.67

Nef increases infectivity of HIV via lipid rafts. Curr Biol (2001) 1.64

The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity (1997) 1.61

Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci U S A (1996) 1.59

Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J Virol (2000) 1.58

Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J Virol (1994) 1.56

A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem (1995) 1.53

CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr Biol (1996) 1.52

Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol (1990) 1.52

Regulation of expression of the human interferon gamma gene. Proc Natl Acad Sci U S A (1985) 1.51

Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J Virol (1990) 1.49

Differences in child pedestrian injury events by location. Pediatrics (1994) 1.48

Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes. J Exp Med (1982) 1.46

Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol (1999) 1.46

Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr (1992) 1.45

Association of the high-affinity receptor for IgG (Fc gamma RI) with the gamma subunit of the IgE receptor. Proc Natl Acad Sci U S A (1993) 1.44

Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength. J Immunol (1985) 1.41

The dynamics of X-inactivation skewing as women age. Clin Genet (2004) 1.37

Structural polymorphism of the human monocyte 40 kilodalton Fc receptor for IgG. J Immunol (1987) 1.36

p21-activated kinase 1 plays a critical role in cellular activation by Nef. Mol Cell Biol (2000) 1.35

Pediatric injury hospitalization in Hispanic children and non-Hispanic white children in southern California. Arch Pediatr Adolesc Med (1996) 1.32

Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes. J Immunol Methods (1994) 1.32

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res (1997) 1.32

The role of the physical and traffic environment in child pedestrian injuries. Pediatrics (1996) 1.30

Functional separation of pseudopod extension and particle internalization during Fc gamma receptor-mediated phagocytosis. J Exp Med (1998) 1.27

Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J Immunol (1987) 1.24

Transcriptional enhancers in the HLA-DQ subregion. Mol Cell Biol (1987) 1.24

Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J Virol (1993) 1.24

Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. Gene (1980) 1.23

A minimal lentivirus Tat. J Virol (1991) 1.21

Family, social, and cultural factors in pedestrian injuries among Hispanic children. Inj Prev (1998) 1.20

Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J Virol (1994) 1.20

Stimulation-induced changes in dimensions of stalks of dendritic spines in the dentate molecular layer. Exp Neurol (1981) 1.20

Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett (2001) 1.19

The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII. J Immunol (1990) 1.19

The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein. Mol Cell Biol (1993) 1.17

Clustering of the platelet Fc gamma receptor induces noncovalent association with the tyrosine kinase p72syk. J Biol Chem (1994) 1.17

Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J Virol (2000) 1.17

Sensitivity of hospitals' E-coded data in identifying causes of children's violence-related injuries. Public Health Rep (1995) 1.17

Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16

Physicochemical separation of two distinct Fc receptors on murine macrophage-like cell lines. J Immunol (1978) 1.15

Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology (1999) 1.14

Expression of MHC II genes. Curr Top Microbiol Immunol (2005) 1.10

Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. An immunohistochemical study. Am J Pathol (1991) 1.10

The class II transactivator CIITA is a transcriptional integrator. Microbes Infect (1999) 1.10

Expression of T cell receptor genes in human B cells. J Exp Med (1986) 1.10

Macrophage receptors for IgE: binding of IgE to specific IgE Fc receptors on a human macrophage cell line, U937. J Immunol (1981) 1.10

The adapter protein LAT enhances fcgamma receptor-mediated signal transduction in myeloid cells. J Biol Chem (2000) 1.10

Use of synthetic oligonucleotide probes complementary to genes for human HLA-DR alpha and beta as extension primers for the isolation of 5'-specific genomic clones. Proc Natl Acad Sci U S A (1983) 1.09

NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun. J Immunol (1990) 1.09

Effect of anisomycin on stimulation-induced changes in dendritic spines of the dentate granule cells. J Neurocytol (1982) 1.08

A tissue-specific transcriptional enhancer is found in the body of the HLA-DR alpha gene. J Exp Med (1987) 1.08

Clustering of the high affinity Fc receptor for immunoglobulin G (Fc gamma RI) results in phosphorylation of its associated gamma-chain. J Biol Chem (1994) 1.07

Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol Cell Biol (1996) 1.07

DNA replication by bacteriophage T4 proteins. The T4 43, 32, 44--62, And 45 proteins are required for strand displacement synthesis at nicks in duplex DNA. J Biol Chem (1979) 1.07

Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals. J Immunol (1990) 1.07

Ultrastructure of Myxidium trachinorum sp. nov. from the gallbladder of the lesser weever fish Echiichthys vipera. Parasitol Res (1999) 1.07

Heteroantibody-mediated cytotoxicity: antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes that is enhanced by interferon-gamma and is not blocked by human IgG. J Immunol (1986) 1.06